Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy
2020 · European Journal of Nuclear Medicine and Molecular Imaging · 97 citations
https://doi.org/10.1007/s00259-020-05057-6
S
Simone U. Dalm
Erasmus MC(NL)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
1.3K
Citations
20
h-index
28
i10-index
Simone U. Dalm is an academic researcher from Erasmus MC. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Peptidase Inhibition and Analysis & Neuroendocrine Tumor Research Advances. The author has an h-index of 20, co-authored 46 publications.
ORCID: 0000-0002-6393-6901Papers by this author
worksGRPr Antagonist <sup>68</sup>Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients
2021 · Journal of Nuclear Medicine · 41 citations
https://doi.org/10.2967/jnumed.120.258814
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine
2022 · European Journal of Nuclear Medicine and Molecular Imaging · 40 citations
https://doi.org/10.1007/s00259-022-05870-1
Progressive APOBEC3B mRNA expression in distant breast cancer metastases
2017 · PLoS ONE · 36 citations
https://doi.org/10.1371/journal.pone.0171343
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity
2022 · European Journal of Nuclear Medicine and Molecular Imaging · 31 citations
https://doi.org/10.1007/s00259-022-05926-2
Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management
2024 · PET Clinics · 13 citations
https://doi.org/10.1016/j.cpet.2024.03.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat